United States:
Latest CMS Rule Impacts Wide Range Of Health Care Stakeholders With Changes For COVID-19 Emergency And Beyond
10 June 2020
Ropes & Gray LLP
To print this article, all you need is to be registered or login on Mondaq.com.
On May 8, 2020, the Centers for Medicare & Medicaid Services
("CMS") published an interim final rule with comment
("IFC") in the Federal Register. The rule includes a wide
range of modifications to CMS regulations governing payment rates,
coverage of telehealth services, conditions of participation, scope
of practice, calculation of medical education payments, and
value-based payment programs – to name a few.
Click here to read the full Alert.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
